Fresenius Medical Care AG (FMS)
22.16
+0.18
(+0.82%)
USD |
NYSE |
Nov 22, 16:00
22.17
+0.01
(+0.05%)
After-Hours: 20:00
Fresenius Medical Care Gross Profit Margin (Quarterly): 24.08% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 24.08% |
June 30, 2024 | 24.46% |
March 31, 2024 | 24.84% |
December 31, 2023 | 27.05% |
September 30, 2023 | 24.90% |
June 30, 2023 | 24.81% |
March 31, 2023 | 24.43% |
December 31, 2022 | 24.63% |
September 30, 2022 | 24.40% |
June 30, 2022 | 26.19% |
March 31, 2022 | 25.81% |
December 31, 2021 | 21.85% |
September 30, 2021 | 28.53% |
June 30, 2021 | 29.72% |
March 31, 2021 | 28.66% |
December 31, 2020 | 31.22% |
September 30, 2020 | 30.79% |
June 30, 2020 | 31.02% |
March 31, 2020 | 30.99% |
December 31, 2019 | 31.74% |
September 30, 2019 | 30.46% |
June 30, 2019 | 30.63% |
March 31, 2019 | 30.62% |
December 31, 2018 | 32.10% |
September 30, 2018 | 31.23% |
Date | Value |
---|---|
June 30, 2018 | 30.95% |
March 31, 2018 | 30.25% |
December 31, 2017 | 34.04% |
September 30, 2017 | 32.85% |
June 30, 2017 | 33.44% |
March 31, 2017 | 35.00% |
December 31, 2016 | 35.17% |
September 30, 2016 | 33.59% |
June 30, 2016 | 33.62% |
March 31, 2016 | 33.06% |
December 31, 2015 | 39.25% |
September 30, 2015 | 32.66% |
June 30, 2015 | 30.90% |
March 31, 2015 | 29.90% |
December 31, 2014 | 32.57% |
September 30, 2014 | 31.32% |
June 30, 2014 | 31.59% |
March 31, 2014 | 30.37% |
December 31, 2013 | 33.77% |
September 30, 2013 | 31.89% |
June 30, 2013 | 32.07% |
March 31, 2013 | 32.03% |
December 31, 2012 | 35.07% |
September 30, 2012 | 32.54% |
June 30, 2012 | 32.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
21.85%
Minimum
Dec 2021
31.74%
Maximum
Dec 2019
27.01%
Average
26.00%
Median
Gross Profit Margin (Quarterly) Benchmarks
BioNTech SE | 85.63% |
Affimed NV | -- |
InflaRx NV | -- |
Immatics NV | -- |
CureVac NV | 95.56% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 4.37% |
Return on Assets | 1.93% |
Return on Invested Capital | 3.14% |
Profit Margin (Quarterly) | 4.47% |
Operating Margin (Quarterly) | 8.87% |
Return on Net Operating Assets | 2.33% |